CIDP causes muscle weakness and numbness, among other symptoms. Diagnosing CIDP involves peripheral nervous system testing, cerebrospinal fluid analysis, and imaging. CIDP is an immune-mediated ...

Doctors can confirm a CIDP diagnosis through several different tests. This article reviews the primary tests involved in determining a CIDP diagnosis, how long they usually take, and what people ...

8,18 Motor and proprioceptive deficits predominate over autonomic symptoms and pain in CIDP. 1 This is attributed to greater susceptibility of motor and proprioceptive nerve fibers to ...

Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy. It affects ...

This can lead to symptoms of CIDP, like muscle weakness, numbness, and the loss of reflexes and sensory input. Although CIDP can cause significant impairment, it is treatable, and as many as 40% ...

Recent research has focused on understanding the underlying mechanisms of CIDP, identifying biomarkers for diagnosis and prognosis, and evaluating treatment strategies. A significant aspect of ...

Chronic inflammatory demyelinating polyneuropathy is an immune-mediated neuropathy that affects the peripheral motor and sensory nerves. The symptoms are of a slowly progressive numbness and tingling ...

and reflex loss are common symptoms of this process in CIDP. With effective treatment, a state of remission in CIDP is possible for some people. This article discusses the first-line therapies for ...

THE family of a "beloved father and husband" who took his own life after Covid-19 vaccine complications are fighting for justice.

The Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) market was valued at USD 968 million in 2017 and is projected to reach USD 2,020.6 million by 2030. The total number of CIDP ...